Journal of Bacteriology & Parasitology

Roles of sulfotopes from glycoconjugates (glycoproteins and sulfatides) in trypanosoma cruzy, the causal agent of chagas disease

Joint Meet on 16^th World Congress on INFECTION PREVENTION AND CONTROL & 5^th International Conference on BACTERIOLOGY

September 16, 2020 | Webinar

Luciana L. Soprano, Maximiliano R. Ferrero, Monica I Esteva, Alicia S. Couto and Vilma G Duschak

National Institute of Parasitol, Argentina
University of Buenos Aires, Argentina

Posters & Accepted Abstracts: J Bacteriol Parasitol

Abstract:

Trypanosoma cruzi, the causative agent of Chagas disease (ChD), contains a major antigen, cruzipain (Cz). Its C-terminal domain (C-T), bears several post-translational modifications The presence of sulfated oligosaccharides was demonstrated in Cz, in a minor antigen with serine-carboxypeptidase activity, and sulfatides Sulfate-bearing glycoproteins in Trypanosomatids are targets of specific immune responses. T. cruzi chronically-infected-subjects mount specific humoral immune responses to sulfated- Cz. In absence of infection, mice immunized with C-T- but not with sulfate-depleted-C-T, showed surprising ultrastructural heart pathological effects. Moreover, the synthetic anionic sugar conjugate NAcGlc6SO3 mimics the N-glycan-linked sulfated epitope (sulfotope) humoral response. Furthermore, the participation of sulfotopes in the immunomodulation by host-parasite interaction via sialic-acid-Iglike- specific-lectins (Siglec) binding to sulfosialylated glycoproteins as well as in the parasite infection process has been reported. Strickingly, recent evidences involved to sulfotopes and their specific antibodies in the immunopathogenesis and infection processes of the experimental ChD. Interestingly, sera from chronically T. cruzi-infected individuals with mild disease displayed higher levels of IgG2 antibodies specific for sulfated glycoproteins and sulfatides compared with those in more severe forms of the disease, evidencing that T. cruzi sulfotopes are antigenic independently of the sulfatedglycoconjugate type. Ongoing assays indicate that antibodies specific for sulfotopes might play a role as predictors of stability from the early stages of chronic ChD and might be considered biomarkers of human ChD progression.

Biography :

Vilma G Duschak, Doctor in Biochemistry (1989) UBA. CONICET Researcher, Argentina since 1994. Post-grade in Medicine Chile University (1990); Cooperation: Instituto-Cs-Biomedicas- San Pablo-University-Brasil (2005) Universite-Jules Verne-Amiens- France (2007) Bernhard Notch Institute of Tropical Medicine, Hamburg, Germany (2010-2011). Editorial Advisory Board Member, Bentham Science Publishers, USA. Awards and distinctions: 6 Publications: more than 40 Assistance to more than 100 National and international congresses. Directed Thesis: 5 Roche Diagnostics International Meeting experts, New York, USA (2016). Evaluator of research projects from ANPCyT, CONICET and UBA (Argentina), OTKA (Hungary) and European Union international projects, Brussels (2018).